Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. |
|---|---|
| Authors: | Luis SA; Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA., Klein AL; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA., Cremer PC; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA.; Departments of Medicine and Radiology, and Multimodality Cardiac Imaging and Clinical Trials Unit Bluhm Cardiovascular Institute, Northwestern University Chicago IL USA., Abbate A; Berne Cardiovascular Research Center University of Virginia Charlottesville VA USA., Salik JR; Cardiology Division Massachusetts General Hospital, Harvard Medical School Boston MA USA., Thomas GK; Virginia Commonwealth University Health System Richmond VA USA., Haider SW; Pericardial Disease Program MedStar Georgetown University Hospital Washington DC USA., Hagerty TE; University of Vermont Medical Center, Larner College of Medicine Burlington VT USA., Lin D; Minneapolis Heart Institute, Abbott Northwestern Hospital/Allina Health Minneapolis MN USA., Waggoner TE; US Heart & Vascular, Tucson Medical Center Tucson AZ USA., Nicholls SJ; Victorian Heart Institute Monash University Melbourne VIC Australia., Kirwan BA; SOCAR Research SA Nyon Switzerland.; Faculty of Epidemiology and Public Health London School of Hygiene and Tropical Medicine London UK., Narine KAD; Cardiol Therapeutics Inc. Oakville ON Canada., Parker AB; Cardiol Therapeutics Inc. Oakville ON Canada., Hamer A; Cardiol Therapeutics Inc. Oakville ON Canada. |
| Source: | Journal of the American Heart Association [J Am Heart Assoc] 2026 Jul 21; Vol. 15 (14), pp. e047605. Date of Electronic Publication: 2026 Jul 10. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42432451 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Luis+SA%22">Luis SA</searchLink>; Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.<br /><searchLink fieldCode="AU" term="%22Klein+AL%22">Klein AL</searchLink>; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA.<br /><searchLink fieldCode="AU" term="%22Cremer+PC%22">Cremer PC</searchLink>; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA.; Departments of Medicine and Radiology, and Multimodality Cardiac Imaging and Clinical Trials Unit Bluhm Cardiovascular Institute, Northwestern University Chicago IL USA.<br /><searchLink fieldCode="AU" term="%22Abbate+A%22">Abbate A</searchLink>; Berne Cardiovascular Research Center University of Virginia Charlottesville VA USA.<br /><searchLink fieldCode="AU" term="%22Salik+JR%22">Salik JR</searchLink>; Cardiology Division Massachusetts General Hospital, Harvard Medical School Boston MA USA.<br /><searchLink fieldCode="AU" term="%22Thomas+GK%22">Thomas GK</searchLink>; Virginia Commonwealth University Health System Richmond VA USA.<br /><searchLink fieldCode="AU" term="%22Haider+SW%22">Haider SW</searchLink>; Pericardial Disease Program MedStar Georgetown University Hospital Washington DC USA.<br /><searchLink fieldCode="AU" term="%22Hagerty+TE%22">Hagerty TE</searchLink>; University of Vermont Medical Center, Larner College of Medicine Burlington VT USA.<br /><searchLink fieldCode="AU" term="%22Lin+D%22">Lin D</searchLink>; Minneapolis Heart Institute, Abbott Northwestern Hospital/Allina Health Minneapolis MN USA.<br /><searchLink fieldCode="AU" term="%22Waggoner+TE%22">Waggoner TE</searchLink>; US Heart & Vascular, Tucson Medical Center Tucson AZ USA.<br /><searchLink fieldCode="AU" term="%22Nicholls+SJ%22">Nicholls SJ</searchLink>; Victorian Heart Institute Monash University Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Kirwan+BA%22">Kirwan BA</searchLink>; SOCAR Research SA Nyon Switzerland.; Faculty of Epidemiology and Public Health London School of Hygiene and Tropical Medicine London UK.<br /><searchLink fieldCode="AU" term="%22Narine+KAD%22">Narine KAD</searchLink>; Cardiol Therapeutics Inc. Oakville ON Canada.<br /><searchLink fieldCode="AU" term="%22Parker+AB%22">Parker AB</searchLink>; Cardiol Therapeutics Inc. Oakville ON Canada.<br /><searchLink fieldCode="AU" term="%22Hamer+A%22">Hamer A</searchLink>; Cardiol Therapeutics Inc. Oakville ON Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580524%22">Journal of the American Heart Association</searchLink> [J Am Heart Assoc] 2026 Jul 21; Vol. 15 (14), pp. e047605. <i>Date of Electronic Publication: </i>2026 Jul 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101580524 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2047-9980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220479980%22">20479980 </searchLink><i>NLM ISO Abbreviation: </i>J Am Heart Assoc <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42432451 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1161/JAHA.125.047605 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e047605 Titles: – TitleFull: Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Luis SA – PersonEntity: Name: NameFull: Klein AL – PersonEntity: Name: NameFull: Cremer PC – PersonEntity: Name: NameFull: Abbate A – PersonEntity: Name: NameFull: Salik JR – PersonEntity: Name: NameFull: Thomas GK – PersonEntity: Name: NameFull: Haider SW – PersonEntity: Name: NameFull: Hagerty TE – PersonEntity: Name: NameFull: Lin D – PersonEntity: Name: NameFull: Waggoner TE – PersonEntity: Name: NameFull: Nicholls SJ – PersonEntity: Name: NameFull: Kirwan BA – PersonEntity: Name: NameFull: Narine KAD – PersonEntity: Name: NameFull: Parker AB – PersonEntity: Name: NameFull: Hamer A IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 07 Text: 2026 Jul 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2047-9980 Numbering: – Type: volume Value: 15 – Type: issue Value: 14 Titles: – TitleFull: Journal of the American Heart Association Type: main |
| ResultId | 1 |